Using a new technique, long-read sequencing, that allows DNA to be analyzed in much greater detail than before, a team of Swedish clinicians and researchers has discovered an unexpected complexity in chromosomal abnormalities. The study, published in Genome Research, opens the door to more precise and effective treatment of patients with rare diseases that currently lack clear diagnoses.